Publications for Shengquan Liu shengquan.liu@tu.edu

Rajagopalan, V., Nguyen, T., Naizghi, G., & Liu, S. (2016). Novel ShetA2 analog, SL-01-18, triggers apoptosis and targets androgen receptors in human prostate cancer cells [Supplemental material]. FASEB Journal, 30(1), 937.1. This material can be found here.

Liu, S., Louie, M. C., Rajagopalan, V., Zhou, G., Ponce, E., Nguyen, T., & Green, L. (2015). Synthesis and evaluation of the diarylthiourea analogs as novel anti-cancer agents. Bioorganic & Medicinal Chemistry Letters, 25(6), 1301-1305. doi:10.1016/j.bmcl.2015.01.042

Nambi, D., Louie, M. C., & Liu, S. (2015). The effects of diarylthiourea analogs on triple negative breast cancer cell growth. Cancer Research, 75 [Article 1774]. doi:10.1158/1538-7445.AM2015-1774

Liu, S. (2010). Adrenergic agents. In J. Block & J. Beale (Eds.), Wilson and Gisvold's textbook of organic medicinal and pharmaceutical chemistry (12th ed., pp. 519-557). Philadelphia, PA: Lippincott Williams & Wilkins.

Liu, S. (2010). Central nervous system depressants. In J. Block & J. Beale (Eds.), Wilson and Gisvold's textbook of organic medicinal and pharmaceutical chemistry (12th ed., pp. 443-470). Philadelphia, PA: Lippincott Williams & Wilkins.

Liu, S., & Louie, M. C. (2010). Novel thiochromane ring modified SHetA2 analogs inhibit growth of ER positive breast cancer cell MCF7. American Journal of Pharmaceutical Education, 74(5), 96. This material can be found here.